PX

P10 Inc

Add to Watchlist

Advanced Chart

12.060

-0.07(-0.577%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

12.765

Open

12.500

VWAP

12.12

Vol

616.78K

Mkt Cap

944.87M

Low

11.990

Amount

7.48M

EV/EBITDA(TTM)

15.62

Total Shares

113.02M

1.33B

EV/OCF(TTM)

15.63

P/S(TTM)

3.61

P10, Inc. is a multi-asset class private markets solutions provider in the alternative asset management industry. The Company provides its investors differentiated access to a broad set of investment solutions that address their diverse investment needs within private markets. The Company structures, manages and monitors portfolios of private market investments, which include specialized funds and customized separate accounts within primary investment funds, secondary investments, direct investments and co-investments (collectively specialized investment vehicles) across highly attractive asset classes and geographies in the middle and lower middle markets. Its portfolio of private solutions includes Private Equity, Venture Capital, and Private Credit. It has a global investor base of over 3,800 investors, across 50 states, 60 countries and six continents, including pension funds, endowments, foundations, corporate pensions and financial institutions.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

79.25M

-6.78%

0.244

-18.59%

74.70M

+0.62%

0.230

-11.68%

71.25M

+0.24%

0.204

-15.02%

Estimates Revision

The market is revising Downward the revenue expectations for P10, Inc. (PX) for FY2025, with the revenue forecasts being adjusted by -0.05% over the past three months. During the same period, the stock price has changed by 5.70%.

Revenue Estimates for FY2025

Revise Downward

-0.05%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-1.22%

In Past 3 Month

Stock Price

Go Up

+5.70%

In Past 3 Month

4 Analyst Rating

27.53% Upside

Wall Street analysts forecast PX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PX is 15.38 USD with a low forecast of 13.00 USD and a high forecast of 20.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

1 Hold

0 Sell

Strong Buy

27.53% Upside

Current: 12.060

Low

13.00

Averages

15.38

High

20.00

27.53% Upside

Current: 12.060

Low

13.00

Averages

15.38

High

20.00

JPMorgan

Overweight

maintain

$15

2025-05-13

Reason

JPMorgan

Price Target

$15

2025-05-13

maintain

Overweight

Reason

JPMorgan lowered the firm's price target on P10 to $14.50 from $15 and keeps an Overweight rating on the shares. P10 reported Q1 ANI per share of 20c, missing the Bloomberg consensus of 21c but in line with the firm's estimate, the analyst tells investors. The firm saw the print as "mixed, with various puts and takes," but continues to like the growth story for P10, noting that its price target decrease reflects a lower average fee rate than previously modeled.

Barclays

Overweight

maintain

$13 -> $14

2025-05-09

Reason

Barclays

Price Target

$13 -> $14

2025-05-09

maintain

Overweight

Reason

Barclays raised the firm's price target on P10 to $14 from $13 and keeps an Overweight rating on the shares. The company's Q1 earnings missed but the tone from management was confident on full year fundraising and activity levels more broadly across the business, the analyst tells investors in a research note.

Morgan Stanley

Michael Cyprys

Hold

Maintains

$14 → $12

2025-04-14

Reason

Morgan Stanley

Michael Cyprys

Price Target

$14 → $12

2025-04-14

Maintains

Hold

Reason

Barclays

Benjamin Budish

Buy

Maintains

$15 → $13

2025-04-07

Reason

Barclays

Benjamin Budish

Price Target

$15 → $13

2025-04-07

Maintains

Buy

Reason

Barclays lowered the firm's price target on P10 to $13 from $15 and keeps an Overweight rating on the shares as part of a Q1 preview for the brokers, asset managers and exchanges. With volatility "in full swing," mergers and initial public offering pipelines are likely to see further delays, the analyst tells investors in a research note. The firm says that while trading activity was generally robust despite a slowdown in crypto, brokers "now face a more intense headwind from a lower in-period Fed funds and futures curve."

Stephens & Co.

John Campbell

Buy

Maintains

$13 → $16

2025-02-13

Reason

Stephens & Co.

John Campbell

Price Target

$13 → $16

2025-02-13

Maintains

Buy

Reason

Barclays

Benjamin Budish

Buy

Maintains

$16 → $15

2025-02-13

Reason

Barclays

Benjamin Budish

Price Target

$16 → $15

2025-02-13

Maintains

Buy

Reason

Barclays lowered the firm's price target on P10 to $15 from $16 and keeps an Overweight rating on the shares post the Q4 report. The company's earnings beat by 15%, driven by lower costs and better margins, the analyst tells investors in a research note. The firm says P10 also considering a change in tax reporting, which could possibly have adverse impacts on the shares.

See All Ratings

Valuation Metrics

The current forward P/E ratio for P10 Inc (PX.N) is 10.69, compared to its 5-year average forward P/E of 13.03. For a more detailed relative valuation and DCF analysis to assess P10 Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued

5Y Average PE

13.03

Current PE

10.69

Overvalued PE

15.17

Undervalued PE

10.89

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

12.95

Current EV/EBITDA

12.06

Overvalued EV/EBITDA

15.64

Undervalued EV/EBITDA

10.27

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

5.35

Current PS

3.62

Overvalued PS

6.82

Undervalued PS

3.89